{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:08:50Z","timestamp":1790352530581,"version":"4.1.0"},"reference-count":304,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["23099"],"award-info":[{"award-number":["23099"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.pharmthera.2025.108847","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:39:42Z","timestamp":1744303182000},"page":"108847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy"],"prefix":"10.1016","volume":"270","author":[{"given":"Elena","family":"Crecca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Di Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Camplone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Vigiano Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Melaiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Mezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cencioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Spallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2025.108847_bb0005","article-title":"Oncogenic signaling pathways in pancreatic ductal adenocarcinoma","volume":"251\u2013283","author":"Agrawal","year":"2023","journal-title":"Advances in Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0010","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.2337\/diacare.28.8.1936","article-title":"Improved meal-related \u03b2-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year","volume":"28","author":"Ahr\u00e9n","year":"2005","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0015","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s005350050309","article-title":"Hypertension as a paraneoplastic syndrome in hepatocellular carcinoma","volume":"34","author":"Akai","year":"1999","journal-title":"Journal of Gastroenterology"},{"issue":"16","key":"10.1016\/j.pharmthera.2025.108847_bb0020","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; World heart federation; International","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"sup1","key":"10.1016\/j.pharmthera.2025.108847_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/00325481.2022.2147326","article-title":"Efficacy and safety of semaglutide for weight management: Evidence from the STEP program","volume":"134","author":"Amaro","year":"2022","journal-title":"Postgraduate Medicine"},{"issue":"Supplement_1","key":"10.1016\/j.pharmthera.2025.108847_bb0030","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc24-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1327154","article-title":"T2DM may exert a protective effect against digestive system tumors in east Asian populations: A Mendelian randomization analysis","volume":"14","author":"An","year":"2024","journal-title":"Frontiers in Oncology"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0040","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/ajg.2012.288","article-title":"Alcohol and tobacco lower the age of presentation in sporadic pancreatic cancer in a dose-dependent manner: A multicenter study","volume":"107","author":"Anderson","year":"2012","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2007.03246.x","article-title":"GI epidemiology: Nonalcoholic fatty liver disease","volume":"25","author":"Angulo","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal Cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15102778","article-title":"Gastric cancer risk in association with underweight, overweight, and obesity: A systematic review and meta-analysis","volume":"15","author":"Azizi","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0060","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0065","article-title":"Prognostic impact of type 2 diabetes in metastatic colorectal cancer","author":"Baleiras","year":"2023","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0070","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jdiacomp.2013.01.004","article-title":"Diabetes mellitus and incidence and mortality of kidney cancer: A meta-analysis","volume":"27","author":"Bao","year":"2013","journal-title":"Journal of Diabetes and its Complications"},{"issue":"32","key":"10.1016\/j.pharmthera.2025.108847_bb0075","doi-asserted-by":"crossref","first-page":"11182","DOI":"10.3748\/wjg.v20.i32.11182","article-title":"Pancreatic ductal adenocarcinoma: Risk factors, screening, and early detection","volume":"20","author":"Becker","year":"2014","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0080","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.diabres.2018.05.024","article-title":"Metabolic syndrome and cancer: \u201cThe common soil hypothesis\u201d","volume":"143","author":"Bellastella","year":"2018","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1158\/1940-6207.CAPR-11-0228","article-title":"Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis","volume":"5","author":"Bhalla","year":"2012","journal-title":"Cancer Prevention Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ijc.26338","article-title":"Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults","volume":"131","author":"Borena","year":"2012","journal-title":"International Journal of Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/annonc\/mdr295","article-title":"Dietary patterns and the risk of esophageal cancer","volume":"23","author":"Bravi","year":"2012","journal-title":"Annals of Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0100","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00125-022-05814-2","article-title":"Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes","volume":"66","author":"Brusco","year":"2023","journal-title":"Diabetologia"},{"issue":"20","key":"10.1016\/j.pharmthera.2025.108847_bb0110","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.3748\/wjg.v18.i20.2545","article-title":"Association between body mass index and erosive esophagitis: A meta-analysis","volume":"18","author":"Cai","year":"2012","journal-title":"World Journal of Gastroenterology"},{"issue":"17","key":"10.1016\/j.pharmthera.2025.108847_bb0115","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.3390\/ijms241713501","article-title":"Fibres and colorectal cancer: Clinical and molecular evidence","volume":"24","author":"Celiberto","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-024-03263-w","article-title":"The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration","volume":"44","author":"Cencioni","year":"2025","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu14081542","article-title":"Gastrointestinal Cancer patient nutritional management: From specific needs to novel epigenetic dietary approaches","volume":"14","author":"Cencioni","year":"2022","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4143\/crt.2023.753","article-title":"The persistence of hypertriglyceridemia and the risk of early onset colorectal Cancer according to tumor subsites: A Nationwide population-based study","volume":"56","author":"Chang","year":"2024","journal-title":"Cancer Research and Treatment"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0135","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","article-title":"Probability of pancreatic Cancer following diabetes: A population-based study","volume":"129","author":"Chari","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/diseases10030044","article-title":"The 8th wonder of the cancer world: Esophageal cancer and inflammation","volume":"10","author":"Chela","year":"2022","journal-title":"Diseases"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ph15111408","article-title":"Simvastatin attenuated tumor growth in different pancreatic tumor animal models","volume":"15","author":"Chen","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0150","first-page":"1","article-title":"Association between cholesterol intake and pancreatic cancer risk: Evidence from a meta-analysis","volume":"5","author":"Chen","year":"2015","journal-title":"Scientific Reports"},{"issue":"17","key":"10.1016\/j.pharmthera.2025.108847_bb0155","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1111\/bph.15149","article-title":"Metformin mitigates gastrointestinal radiotoxicity and radiosensitises P53 mutation colorectal tumours via optimising autophagy","volume":"177","author":"Chen","year":"2020","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23872","article-title":"Metabolic syndrome and risk of colorectal cancer: A Mendelian randomization study","volume":"10","author":"Chen","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-018-0946-7","article-title":"Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: A cell-molecular study","volume":"17","author":"Chen","year":"2018","journal-title":"Lipids in Health and Disease"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0170","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/hep.27014","article-title":"Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderly","volume":"59","author":"Chiang","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/nu15020467","article-title":"Does bariatric surgery reduce the risk of colorectal cancer in individuals with morbid obesity? A systematic review and meta-analysis","volume":"15","author":"Chierici","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0180","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.23593","article-title":"Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice","volume":"123","author":"Cho","year":"2008","journal-title":"International Journal of Cancer"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071599","article-title":"Association between lipid profiles and the incidence of hepatocellular carcinoma: A nationwide population-based study","volume":"13","author":"Cho","year":"2021","journal-title":"Cancers"},{"issue":"17","key":"10.1016\/j.pharmthera.2025.108847_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174265","article-title":"Advances in Immunotherapeutics in pancreatic ductal adenocarcinoma","volume":"15","author":"Chouari","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","article-title":"Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link","volume":"28","author":"Chrysavgis","year":"2022","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.687585","article-title":"Hydrophilic or lipophilic statins?","volume":"8","author":"Climent","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0205","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1161\/HYP.0000000000000224","article-title":"Cancer therapy-related hypertension: A scientific statement from the American Heart Association","volume":"80","author":"Cohen","year":"2023","journal-title":"Hypertension"},{"issue":"9326","key":"10.1016\/j.pharmthera.2025.108847_bb0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial","volume":"360","author":"Collins","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0215","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41575-019-0109-y","article-title":"Molecular subtypes of pancreatic cancer","volume":"16","author":"Collisson","year":"2019","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0220","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nature Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0225","article-title":"Association of hypertension and organ-specific cancer: A meta-analysis","volume":"10","author":"Connaughton","year":"2022","journal-title":"Healthcare (Basel)"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0230","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1572-0241.2006.00849.x","article-title":"Body mass index and gastroesophageal reflux disease: A systematic review and meta-analysis","volume":"101","author":"Corley","year":"2006","journal-title":"American Journal of Gastroenterology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2025.108847_bb0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000477773","article-title":"Tumor heterogeneity in pancreatic adenocarcinoma","volume":"85","author":"Cros","year":"2018","journal-title":"Pathobiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/d41573-019-00198-2","article-title":"Blocking PCSK9 enhances immune checkpoint therapy","volume":"20","author":"Crunkhorn","year":"2020","journal-title":"Nature Reviews Drug Discovery"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0245","article-title":"Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway","volume":"10","author":"Da Wang","year":"2021","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0250","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.advms.2023.07.002","article-title":"Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin","volume":"68","author":"Dautovi\u0107","year":"2023","journal-title":"Advances in Medical Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0255","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s11695-023-06674-4","article-title":"The impact of bariatric surgery on the incidence of colorectal Cancer in patients with obesity\u2014A systematic review and Meta-analysis of registry data","volume":"33","author":"Davey","year":"2023","journal-title":"Obesity Surgery"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2024.159578","article-title":"Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies","volume":"1870","author":"Daya","year":"2024","journal-title":"Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb0265","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/cncr.35235","article-title":"The association of metabolic syndrome score trajectory patterns with risk of all cancer types","volume":"130","author":"Deng","year":"2024","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0270","doi-asserted-by":"crossref","first-page":"272","DOI":"10.23736\/S2724-6507.21.03405-9","article-title":"Prediabetes: How pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences","volume":"46","author":"Di Giuseppe","year":"2021","journal-title":"Minerva Endocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0275","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tem.2023.02.001","article-title":"First-phase insulin secretion: Can its evaluation direct therapeutic approaches?","volume":"34","author":"Di Giuseppe","year":"2023","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"19","key":"10.1016\/j.pharmthera.2025.108847_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu15194202","article-title":"Physical activity and type 2 diabetes: In search of a personalized approach to improving \u03b2-cell function","volume":"15","author":"Di Murro","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0285","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.OGX.0000055759.75837.E7","article-title":"Reduction of the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"58","author":"Diabetes Prevention Program Research Group","year":"2003","journal-title":"Obstetrical & Gynecological Survey"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb0290","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jso.24578","article-title":"Colorectal cancer\u2014Global burden, trends, and geographical variations","volume":"115","author":"Douaiher","year":"2017","journal-title":"Journal of Surgical Oncology"},{"issue":"October","key":"10.1016\/j.pharmthera.2025.108847_bb0295","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.canlet.2016.10.019","article-title":"Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression","volume":"385","author":"Duan","year":"2017","journal-title":"Cancer Letters"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0300","first-page":"219","article-title":"Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas","volume":"71","author":"Eggens","year":"1990","journal-title":"Journal of Experimental Pathology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0305","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s12010-022-04203-0","article-title":"Simvastatin induces apoptosis and suppresses hepatocellular carcinoma induced In rats","volume":"195","author":"Elleithi","year":"2023","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb0310","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0016-5085(03)00157-4","article-title":"Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms","volume":"124","author":"El-Omar","year":"2003","journal-title":"Gastroenterology"},{"issue":"7503","key":"10.1016\/j.pharmthera.2025.108847_bb0315","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0320","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4251\/wjgo.v15.i4.571","article-title":"Recent advances in targeted therapy for pancreatic adenocarcinoma","volume":"15","author":"Fang","year":"2023","journal-title":"World Journal of Gastrointestinal Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cddis.2014.59","article-title":"Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating Stat3 signaling","volume":"5","author":"Feng","year":"2014","journal-title":"Cell Death and Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0330","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41574-023-00833-4","article-title":"Metformin: Update on mechanisms of action and repurposing potential","volume":"19","author":"Foretz","year":"2023","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.semcancer.2020.10.007","article-title":"HDL and cancer - causality still needs to be confirmed? Update 2020","volume":"73","author":"Ganjali","year":"2021","journal-title":"Seminars in Cancer Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb0340","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ng.3076","article-title":"Genetic landscape of esophageal squamous cell carcinoma","volume":"46","author":"Gao","year":"2014","journal-title":"Nature Genetics"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0345","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","article-title":"AMPK: Mechanisms of cellular energy sensing and restoration of metabolic balance","volume":"66","author":"Garcia","year":"2017","journal-title":"Molecular Cell"},{"issue":"C","key":"10.1016\/j.pharmthera.2025.108847_bb0350","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/B978-0-12-381517-0.00014-X","article-title":"Wnt and incretin connections","volume":"84","author":"Garc\u00eda-Jim\u00e9nez","year":"2010","journal-title":"Vitamins and Hormones"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0355","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbagrm.2014.07.020","article-title":"Insulin drives glucose-dependent insulinotropic peptide expression via glucose-dependent regulation of FoxO1 and LEF1\/\u03b2-catenin","volume":"1839","author":"Garc\u00eda-Mart\u00ednez","year":"2014","journal-title":"Biochimica et Biophysica Acta, Gene Regulatory Mechanisms"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0360","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jss.2020.11.016","article-title":"Statins inhibit toll-like receptor 4\u2013mediated growth of human esophageal adenocarcinoma cells","volume":"260","author":"Gergen","year":"2021","journal-title":"Journal of Surgical Research"},{"issue":"10193","key":"10.1016\/j.pharmthera.2025.108847_bb0365","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"The Lancet"},{"issue":"March","key":"10.1016\/j.pharmthera.2025.108847_bb0370","article-title":"Hyperglycemia-driven signaling bridges between diabetes and cancer","volume":"229","author":"Ghareghomi","year":"2024","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111552","article-title":"Dietary risk factors for esophageal cancer based on World Health Organization regions","volume":"95","author":"Ghosh","year":"2022","journal-title":"Nutrition"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0380","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1749-6632.2000.tb06318.x","article-title":"Endothelial dysfunction, hemodynamic forces, and atherogenesis","volume":"902","author":"Gimbrone","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"April","key":"10.1016\/j.pharmthera.2025.108847_bb0385","article-title":"Hepatocellular carcinoma in a large cohort of type 2 diabetes patients","volume":"200","author":"Giorda","year":"2023","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0390","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.2337\/dc07-0627","article-title":"Effect of initial combination therapy with Sitagliptin, a dipeptidyl Peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes","volume":"30","author":"Goldstein","year":"2007","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-023-01798-4","article-title":"Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)","volume":"22","author":"Gourdy","year":"2023","journal-title":"Cardiovascular Diabetology"},{"issue":"13","key":"10.1016\/j.pharmthera.2025.108847_bb0400","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","article-title":"Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus","volume":"342","author":"Gress","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0405","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/01.CIR.0000111245.75752.C6","article-title":"Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.pharmthera.2025.108847_bb0410","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the Management of Blood Cholesterol: Executive summary: A report of the American College of Cardiology\/American Heart Association task force on Clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: Recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"Journal of Hematology and Oncology"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0420","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1073\/pnas.1421601112","article-title":"Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma","volume":"112","author":"Guillaumond","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0425","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nature Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108847_bb0430","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/COC.0000000000000388","article-title":"Obesity is independently associated with increased risk of hepatocellular Cancer\u2013related mortality: A systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2018","journal-title":"American Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0435","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/2230-8210.111625","article-title":"Glucagon-like peptide-1 analogues: An overview","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.3000732","article-title":"Paradoxical activation of AMPK by glucose drives selective EP300 activity in colorectal cancer","volume":"18","author":"Guti\u00e9rrez-Salmer\u00f3n","year":"2020","journal-title":"PLoS Biology"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb0445","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1021\/jacs.0c00650","article-title":"Metformin-induced stromal depletion to enhance the penetration of gemcitabine-loaded magnetic nanoparticles for pancreatic cancer targeted therapy","volume":"142","author":"Han","year":"2020","journal-title":"Journal of the American Chemical Society"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-50328-5","article-title":"Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis","volume":"13","author":"Hansen","year":"2023","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0455","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12029-021-00648-4","article-title":"Statins as potential therapeutics for esophageal Cancer","volume":"52","author":"Hassanabad","year":"2021","journal-title":"Journal of Gastrointestinal Cancer"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0460","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(22)00085-7","article-title":"Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: A multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial","volume":"10","author":"Heise","year":"2022","journal-title":"The Lancet Diabetes and Endocrinology"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2025.108847_bb0465","first-page":"15","article-title":"The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle","volume":"378","author":"Henriksen","year":"2012","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"24","key":"10.1016\/j.pharmthera.2025.108847_bb0470","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011-2016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0475","first-page":"251","article-title":"Gastric cancer: Classification, histology and application of molecular pathology","volume":"3","author":"Hu","year":"2012","journal-title":"Journal of Gastrointestinal Oncology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0480","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.ijcard.2013.04.106","article-title":"Baseline hypertension: New insight into the potential predictors of survival in patients with hepatocellular carcinoma","volume":"168","author":"Hu","year":"2013","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1132306","article-title":"Risk factors for early-onset colorectal cancer: Systematic review and meta-analysis","volume":"13","author":"Hua","year":"2023","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0490","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04263-8","article-title":"Metformin and cancer hallmarks: Shedding new lights on therapeutic repurposing","volume":"21","author":"Hua","year":"2023","journal-title":"Journal of Translational Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0495","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.asjsur.2016.10.005","article-title":"Esophageal cancer: Risk factors, genetic association, and treatment","volume":"41","author":"Huang","year":"2018","journal-title":"Asian Journal of Surgery"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0500","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.RES.0000170705.56583.45","article-title":"Unraveling the links between diabetes, obesity, and cardiovascular disease","volume":"96","author":"Huang","year":"2005","journal-title":"Circulation Research"},{"issue":"5\u20136","key":"10.1016\/j.pharmthera.2025.108847_bb0505","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"DMM Disease Models and Mechanisms"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0510","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0016-5085(70)80004-X","article-title":"Histological consequences of gastroesophageal reflux in man","volume":"58","author":"Ismail-Beigi","year":"1970","journal-title":"Gastroenterology"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108847_bb0515","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1056\/NEJMoa054391","article-title":"Body-mass index and symptoms of gastroesophageal reflux in women","volume":"354","author":"Jacobson","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0520","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/j.gastro.2020.01.044","article-title":"Identification of subtypes of Barrett\u2019s esophagus and esophageal adenocarcinoma based on DNA methylation profiles and integration of transcriptome and genome data","volume":"158","author":"Jammula","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0525","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/ijerph20043640","article-title":"The rise of gastrointestinal cancers as a global phenomenon: Unhealthy behavior or Progress?","volume":"20","author":"Jardim","year":"2023","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0530","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70174","article-title":"PCSK9 inhibitors: the evolving future","volume":"7","author":"Jeswani","year":"2024","journal-title":"Health Science Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0535","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/diabetology4020015","article-title":"Progress in understanding metabolic syndrome and knowledge of its complex pathophysiology","volume":"4","author":"Jha","year":"2023","journal-title":"Diabetology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0540","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7150\/jca.13837","article-title":"The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma","volume":"7","author":"Jiang","year":"2016","journal-title":"Journal of Cancer"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0545","article-title":"Statins\u00a0: A repurposed drug to fight cancer","volume":"1\u201333","author":"Jiang","year":"2021","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0550","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.amjcard.2021.07.049","article-title":"Relation of the metabolic syndrome to incident colorectal cancer in young adults aged 20 to 49 years","volume":"158","author":"Jimba","year":"2021","journal-title":"American Journal of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0555","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/dom.12059","article-title":"The efficacy and safety of ezetimibe\/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome","volume":"15","author":"Jimenez","year":"2012","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0560","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2022.05.032","article-title":"Association between metabolic syndrome and the risk of colorectal cancer diagnosed before age 50 years according to tumor location","volume":"163","author":"Jin","year":"2022","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0565","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/MCG.0b013e3182a030c4","article-title":"The association between metabolic syndrome and hepatocellular carcinoma: Systemic review and meta-analysis","volume":"48","author":"Jinjuvadia","year":"2014","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0570","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/01.HYP.35.3.807","article-title":"Overweight and hypertension","volume":"35","author":"Julius","year":"2000","journal-title":"Hypertension"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108847_bb0575","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022479","article-title":"Untreated hypertension and subsequent incidence of colorectal cancer: Analysis of a nationwide epidemiological database","volume":"10","author":"Kaneko","year":"2021","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0580","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1158\/1535-7163.MCT-11-0594","article-title":"The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo","volume":"11","author":"Kato","year":"2012","journal-title":"Molecular Cancer Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0585","first-page":"12","article-title":"Hypertension in metabolic syndrome: Novel insights","volume":"16","author":"Katsimardou","year":"2019","journal-title":"Current Hypertension Reviews"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb0590","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: Emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum","year":"2019","journal-title":"Nature Reviews Gastroenterology and Hepatology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0595","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/JHC.S44381","article-title":"Hepatocellular carcinoma: Epidemiology and risk factors","volume":"1","author":"Kew","year":"2014","journal-title":"Journal of Hepatocellular Carcinoma"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102828","article-title":"Association of diabetes mellitus with early-onset colorectal cancer: A systematic review and meta-analysis of 19 studies including 10 million individuals and 30,000 events","volume":"17","author":"Khoa Ta","year":"2023","journal-title":"Diabetes and Metabolic Syndrome: Clinical Research and Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0605","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, diabetes, and increased cancer progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes and Metabolism Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0610","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4070\/kcj.2021.0328","article-title":"Lifestyle modification in the management of metabolic syndrome: Statement from Korean society of CardioMetabolic syndrome (KSCMS)","volume":"52","author":"Kim","year":"2021","journal-title":"Korean Circulation Journal"},{"issue":"15","key":"10.1016\/j.pharmthera.2025.108847_bb0615","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: Molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.pharmthera.2025.108847_bb0620","doi-asserted-by":"crossref","first-page":"56546","DOI":"10.18632\/oncotarget.17798","article-title":"Metformin increases chemo-sensitivity via gene downregulation encoding DNA replication proteins in 5-Fu resistant colorectal cancer cells","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"issue":"May","key":"10.1016\/j.pharmthera.2025.108847_bb0625","first-page":"3362","article-title":"Glucagon-like peptide-1 receptor activation inhibits growth and augments apoptosis in murine CT26 Colon","volume":"152","author":"Koehler","year":"2015","journal-title":"Cancer Cells"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0630","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCULATIONAHA.115.020406","article-title":"Shared risk factors in cardiovascular disease and cancer","volume":"133","author":"Koene","year":"2016","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.pharmthera.2025.108847_bb0635","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.3390\/ijms21165722","article-title":"Glucagon-like peptide-1 receptor agonist prevented the progression of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis","volume":"21","author":"Kojima","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb0640","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41371-023-00825-x","article-title":"Preexisting hypertension and cancer therapy: Evidence, pathophysiology, and management recommendation","volume":"37","author":"Koskina","year":"2023","journal-title":"Journal of Human Hypertension"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0645","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.21873\/invivo.13035","article-title":"Clinicopathological prognostic factors determining outcomes of treatment in gastric cancer surgery","volume":"36","author":"Kulig","year":"2022","journal-title":"In Vivo"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0650","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11894-023-00899-0","article-title":"Esophageal cancer: Overview, risk factors, and reasons for the rise","volume":"25","author":"Lander","year":"2023","journal-title":"Current Gastroenterology Reports"},{"issue":"3 SUPPL","key":"10.1016\/j.pharmthera.2025.108847_bb0655","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00004872-200103001-00001","article-title":"Insulin-mediated sympathetic stimulation: Role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why)","volume":"19","author":"Landsberg","year":"2001","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0660","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1226655","article-title":"Insulin signaling and its application","volume":"14","author":"Le","year":"2023","journal-title":"Frontiers in Endocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-023-02954-2","article-title":"Synergistic apoptosis by combination of metformin and an O-GlcNAcylation inhibitor in colon cancer cells","volume":"23","author":"Lee","year":"2023","journal-title":"Cancer Cell International"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb0670","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1158\/1055-9965.EPI-22-0703","article-title":"Association between metabolic syndrome and risk of esophageal cancer: A Nationwide population-based study","volume":"31","author":"Lee","year":"2022","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0675","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/dom.15374","article-title":"Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trial","volume":"26","author":"Lee","year":"2023","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0680","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-024-00608-6","article-title":"The causal associations of circulating lipids with Barrett\u2019s esophagus and esophageal cancer: A bi-directional, two sample mendelian randomization analysis","volume":"18","author":"Li","year":"2024","journal-title":"Human Genomics"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0685","first-page":"1","article-title":"Biomarkers of lipid metabolism in gastric cancer: A case control study","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0690","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00326","article-title":"The association between metabolic syndrome and gastric cancer in Chinese","volume":"8","author":"Li","year":"2018","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0695","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/j.gastro.2021.12.239","article-title":"Associations of body mass index at different ages with early-onset colorectal cancer","volume":"162","author":"Li","year":"2022","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0700","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1159\/000495539","article-title":"Metformin inhibited growth, invasion and metastasis of esophageal squamous cell carcinoma in vitro and in vivo","volume":"51","author":"Liang","year":"2018","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"18","key":"10.1016\/j.pharmthera.2025.108847_bb0705","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.18632\/oncotarget.23774","article-title":"Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma","volume":"9","author":"Liang","year":"2018","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb0710","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ng.2935","article-title":"Genomic and molecular characterization of esophageal squamous cell carcinoma","volume":"46","author":"Lin","year":"2014","journal-title":"Nature Genetics"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108847_bb0715","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jjco\/hyu082","article-title":"Body mass index and risk of gastric cancer: A meta-analysis","volume":"44","author":"Lin","year":"2014","journal-title":"Japanese Journal of Clinical Oncology"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb0720","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/met.2019.0070","article-title":"Genome-wide association study of the metabolic syndrome in UK biobank","volume":"17","author":"Lind","year":"2019","journal-title":"Metabolic Syndrome and Related Disorders"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb0725","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","article-title":"The Finnish diabetes prevention study (DPS)","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108847_bb0730","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.2337\/dc20-0204","article-title":"Association of type 2 diabetes with cancer: A meta-analysis with bias analysis for unmeasured confounding in 151 cohorts comprising 32 million people","volume":"43","author":"Ling","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb0735","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/bcp.13944","article-title":"Statins popularity: A global picture","volume":"85","author":"Lippi","year":"2019","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0740","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2147\/OTT.S237693","article-title":"Simvastatin inhibits the malignant behaviors of gastric cancer cells by simultaneously suppressing YAP and \u03b2-catenin signaling","volume":"13","author":"Liu","year":"2020","journal-title":"Oncotargets and Therapy"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102896","article-title":"Association of the age of onset of metabolic syndrome with the risk of all cancer types","volume":"17","author":"Liu","year":"2023","journal-title":"Diabetes and Metabolic Syndrome: Clinical Research and Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0750","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/cam4.4923","article-title":"Genetic risk, metabolic syndrome, and gastrointestinal cancer risk: A prospective cohort study","volume":"12","author":"Liu","year":"2023","journal-title":"Cancer Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb0755","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI29044","article-title":"AMP-activated protein kinase signaling in metabolic regulation find the latest version\u00a0: Review series AMP-activated protein kinase signaling in metabolic regulation","volume":"116","author":"Long","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0760","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jgh.16042","article-title":"The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review","volume":"38","author":"Lu","year":"2023","journal-title":"Journal of Gastroenterology and Hepatology (Australia)"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0765","first-page":"1271","article-title":"Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR\/AKT signalling","volume":"54","author":"Lu","year":"2019","journal-title":"International Journal of Oncology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0770","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/codi.16092","article-title":"Systematic review and meta-analysis: Associations between metabolic syndrome and colorectal neoplasia outcomes","volume":"24","author":"Lu","year":"2022","journal-title":"Colorectal Disease"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0775","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/cac2.12220","article-title":"A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors","volume":"41","author":"Lu","year":"2021","journal-title":"Cancer Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0780","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/nyas.12098","article-title":"Type 2 diabetes in east Asians: Similarities and differences with populations in Europe and the United States","volume":"1281","author":"Ma","year":"2013","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0785","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice","volume":"54","author":"Maida","year":"2011","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb0790","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41431-023-01301-3","article-title":"Abdominal obesity is a more important causal risk factor for pancreatic cancer than overall obesity","volume":"31","author":"Maina","year":"2023","journal-title":"European Journal of Human Genetics"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0795","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The impact of dietary fiber on gut microbiota in host health and disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host & Microbe"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0800","doi-asserted-by":"crossref","DOI":"10.37029\/jcas.v9i2.473","article-title":"Systemic diseases and risk of developing gastrointestinal Cancer","volume":"9","author":"Malkani","year":"2023","journal-title":"Journal of Cancer & Allied Specialties"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0805","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","article-title":"New-onset diabetes and antihypertensive drugs","volume":"24","author":"Mancia","year":"2005","journal-title":"Journal of Hypertension"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb0810","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension","volume":"41","author":"Mancia","year":"2023","journal-title":"Journal of Hypertension"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0815","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00109-013-1095-0","article-title":"Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products","volume":"92","author":"Manu","year":"2014","journal-title":"Journal of Molecular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0820","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/edm2.462","article-title":"Glucagon-like peptide agonists: A prospective review","volume":"7","author":"Mariam","year":"2024","journal-title":"Endocrinology, Diabetes and Metabolism"},{"issue":"19","key":"10.1016\/j.pharmthera.2025.108847_bb0825","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb0830","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101043","article-title":"Influence of cholesterol on cancer progression and therapy","volume":"14","author":"Mayengbam","year":"2021","journal-title":"Translational Oncology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0840","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/osp4.84","article-title":"Liraglutide for weight management: A critical review of the evidence","volume":"3","author":"Mehta","year":"2017","journal-title":"Obesity Science and Practice"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb0845","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028813","article-title":"Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites","volume":"6","author":"Menter","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb0850","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.tem.2020.07.003","article-title":"Endocrine and metabolic insights from pancreatic surgery","volume":"31","author":"Mezza","year":"2020","journal-title":"Trends in Endocrinology and Metabolism"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb0855","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146788","article-title":"Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional \u03b2 cells in predicting diabetes","volume":"131","author":"Mezza","year":"2021","journal-title":"The Journal of Clinical Investigation"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb0860","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2337\/db18-0279","article-title":"Increased B-cell workload modulates proinsulin-to-insulin ratio in humans","volume":"67","author":"Mezza","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0865","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.722450","article-title":"Association of dietary cholesterol intake with risk of gastric cancer: A systematic review and meta-analysis of observational studies","volume":"8","author":"Miao","year":"2021","journal-title":"Frontiers in Nutrition"},{"issue":"27","key":"10.1016\/j.pharmthera.2025.108847_bb0870","doi-asserted-by":"crossref","first-page":"44881","DOI":"10.18632\/oncotarget.16487","article-title":"Diabetes mellitus and the risk of gastric cancer: A meta-analysis of cohort studies","volume":"8","author":"Miao","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0875","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/clpt.2010.184","article-title":"Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active glp-1","volume":"88","author":"Migoya","year":"2010","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jjcc.2008.05.001","article-title":"Beneficial effects of ezetimibe-based therapy in patients with dyslipidemia","volume":"52","author":"Miura","year":"2008","journal-title":"Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102353","article-title":"Metabolic syndrome is linked to the incidence of pancreatic cancer","volume":"67","author":"Miyashita","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb0890","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.focha.2023.100335","article-title":"Metabolic syndrome: Risk factors, diagnosis, pathogenesis, and management with natural approaches","volume":"3","author":"Mohamed","year":"2023","journal-title":"Food Chemistry Advances"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0900","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/dc10-0879","article-title":"Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006","volume":"34","author":"Mozumdar","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb0905","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/jnci\/djac011","article-title":"Associations between glycemic traits and colorectal cancer: A Mendelian randomization analysis","volume":"114","author":"Murphy","year":"2022","journal-title":"Journal of the National Cancer Institute"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb0910","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamacardio.2019.0886","article-title":"Effect of the PCSK9 inhibitor Evolocumab on total cardiovascular events in patients with cardiovascular disease","volume":"4","author":"Murphy","year":"2019","journal-title":"JAMA Cardiology"},{"issue":"7407","key":"10.1016\/j.pharmthera.2025.108847_bb0915","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Muzny","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0920","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0945-053X(03)00006-4","article-title":"Prolyl 4-hydroxylases, the key enzymes of collagen biosynthesis","volume":"22","author":"Myllyharju","year":"2003","journal-title":"Matrix Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb0925","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.3892\/ijo.2016.3676","article-title":"Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma","volume":"49","author":"Nakayama","year":"2016","journal-title":"International Journal of Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0930","doi-asserted-by":"crossref","first-page":"141","DOI":"10.7570\/jomes22045","article-title":"Constant association between low high-density lipoprotein cholesterol and gastric cancer regardless of site","volume":"32","author":"Nam","year":"2023","journal-title":"Journal of Obesity and Metabolic Syndrome"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0935","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47193-9","article-title":"A population-based cohort study of longitudinal change of high-density lipoprotein cholesterol impact on gastrointestinal cancer risk","volume":"15","author":"Nam","year":"2024","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0940","doi-asserted-by":"crossref","DOI":"10.4103\/jrms.jrms_267_22","article-title":"The tangled web of dyslipidemia and cancer: Is there any association?","volume":"27","author":"Neshat","year":"2022","journal-title":"Journal of Research in Medical Sciences"},{"issue":"9501","key":"10.1016\/j.pharmthera.2025.108847_bb0945","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)67780-X","article-title":"The metabolic syndrome","volume":"366","author":"Neuhauser","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0950","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-024-01556-0","article-title":"A review article: The relationship between obesity and colorectal cancer","volume":"25","author":"Nguyen","year":"2024","journal-title":"Current Diabetes Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0955","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.gastro.2019.08.059","article-title":"Pathways of colorectal carcinogenesis","volume":"158","author":"Nguyen","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0960","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.290.1.66","article-title":"Obesity and estrogen as risk factors for gastroesophageal reflux symptoms","volume":"290","author":"Nilsson","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb0965","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.dsx.2014.04.026","article-title":"Clustering of cardiometabolic risk factors and risk of elevated HbA1c in non-Hispanic White, non-Hispanic black and Mexican-American adults with type 2 diabetes","volume":"8","author":"Okosun","year":"2014","journal-title":"Diabetes and Metabolic Syndrome: Clinical Research and Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb0970","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annual Review of Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0975","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cgh.2021.01.037","article-title":"Risk factors for early-onset colorectal cancer: A systematic review and meta-analysis","volume":"20","author":"O\u2019Sullivan","year":"2022","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0980","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","article-title":"Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain","volume":"348","author":"Owen","year":"2000","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2025.108847_bb0985","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175721","article-title":"The evolving landscape of PCSK9 inhibition in cancer","volume":"949","author":"Oza","year":"2023","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb0990","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jash.2007.07.004","article-title":"Metabolic complications associated with use of thiazide diuretics","volume":"1","author":"Palmer","year":"2007","journal-title":"Journal of the American Society of Hypertension"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb0995","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.22734","article-title":"Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liverfibrosis: A pathological analysis","volume":"49","author":"Paradis","year":"2009","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.pharmthera.2025.108847_bb1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15143634","article-title":"Overview of pancreatic cancer epidemiology in Europe and recommendations for screening in high-risk populations","volume":"15","author":"Partyka","year":"2023","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.pharmthera.2025.108847_bb1005","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1080\/10408398.2022.2164245","article-title":"Dietary fiber as a wide pillar of colorectal cancer prevention and adjuvant therapy","volume":"64","author":"Pedrosa","year":"2024","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"21","key":"10.1016\/j.pharmthera.2025.108847_bb1010","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non\u2013calcium antagonist hypertension treatment strategy for patients with coronary artery disease","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of Liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4178\/epih.e2020004","article-title":"Risk factors for stomach cancer: A systematic review and meta-analysis","volume":"42","author":"Poorolajal","year":"2020","journal-title":"Epidemiology and Health"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2021.688377","article-title":"The current treatment paradigm for pancreatic ductal adenocarcinoma and barriers to therapeutic efficacy","volume":"11","author":"Principe","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108847_bb1030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1872-034X.2012.01007.x","article-title":"In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma","volume":"42","author":"Qu","year":"2012","journal-title":"Hepatology Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb1035","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s40200-022-01009-z","article-title":"Metabolic syndrome and underlying genetic determinants - a systematic review","volume":"21","author":"Rana","year":"2022","journal-title":"Journal of Diabetes & Metabolic Disorders"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb1045","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S2213-8587(19)30158-5","article-title":"Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: A prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","volume":"7","author":"Ray","year":"2019","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4267357","article-title":"Safety and mode of action of diabetes medications in comparison with 5-Aminolevulinic acid (5-ALA)","volume":"2019","author":"Rehani","year":"2019","journal-title":"Journal of Diabetes Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2013.tb00484.x","article-title":"Metabolic syndrome and insulin resistance: Underlying causes and modification by exercise training","volume":"3","author":"Roberts","year":"2013","journal-title":"Comprehensive Physiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb1060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944717711379","article-title":"Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds","volume":"11","author":"Rochlani","year":"2017","journal-title":"Therapeutic Advances in Cardiovascular Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1065","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-015-0075-5","article-title":"Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe\/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk","volume":"14","author":"Rosen","year":"2015","journal-title":"Lipids in Health and Disease"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb1070","doi-asserted-by":"crossref","first-page":"e1338","DOI":"10.1016\/j.cgh.2021.10.016","article-title":"Metabolic syndrome and risk of gastrointestinal cancers: An investigation using large-scale molecular data","volume":"20","author":"Rothwell","year":"2022","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1075","doi-asserted-by":"crossref","DOI":"10.1007\/s11906-018-0812-z","article-title":"The global epidemic of the metabolic syndrome","volume":"20","author":"Saklayen","year":"2018","journal-title":"Current Hypertension Reports"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb1080","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1634\/theoncologist.2018-0143","article-title":"Comparative molecular analyses of esophageal squamous cell carcinoma, esophageal adenocarcinoma, and gastric adenocarcinoma","volume":"23","author":"Salem","year":"2018","journal-title":"The Oncologist"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","article-title":"Metabolic syndrome","volume":"43","author":"Samson","year":"2014","journal-title":"Endocrinology and Metabolism Clinics of North America"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1172\/JCI77812","article-title":"The pathogenesis of insulin resistance: Integrating signaling pathways and substrate flux","volume":"126","author":"Samuel","year":"2016","journal-title":"Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb1095","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2036.2010.04271.x","article-title":"Systematic review: The association between obesity and hepatocellular carcinoma - epidemiological evidence","volume":"31","author":"Saunders","year":"2010","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb1100","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1172\/JCI29024","article-title":"Insulin resistance and atherosclerosis","volume":"116","author":"Semenkovich","year":"2006","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67329-3","article-title":"Hypertension is associated with oral, laryngeal, and esophageal cancer: A nationwide population-based study","volume":"10","author":"Seo","year":"2020","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-45014-4","article-title":"Association between blood pressure and risk of cancer development: A systematic review and meta-analysis of observational studies","volume":"9","author":"Seretis","year":"2019","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb1115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41571-023-00757-y","article-title":"Improving outcomes in patients with oesophageal cancer","volume":"20","author":"Shah","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1120","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.gastro.2018.04.025","article-title":"Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanwpc.2022.100596","article-title":"Association between age at diabetes onset or diabetes duration and subsequent risk of pancreatic cancer: Results from a longitudinal cohort and mendelian randomization study","volume":"30","author":"Shen","year":"2023","journal-title":"The Lancet Regional Health - Western Pacific"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb1130","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00384-021-03974-y","article-title":"Metabolic syndrome and the risk of colorectal cancer: A systematic review and meta-analysis","volume":"36","author":"Shen","year":"2021","journal-title":"International Journal of Colorectal Disease"},{"issue":"16","key":"10.1016\/j.pharmthera.2025.108847_bb1135","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.7150\/jca.25640","article-title":"A comprehensive look at the role of hyperlipidemia in promoting colorectal cancer liver metastasis","volume":"9","author":"Shen","year":"2018","journal-title":"Journal of Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1140","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3892\/mmr.2016.5592","article-title":"Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo","volume":"14","author":"Shi","year":"2016","journal-title":"Molecular Medicine Reports"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1145","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb1150","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","article-title":"Global patterns and trends in colorectal cancer incidence in young adults","volume":"68","author":"Siegel","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1155","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2019.06.048","article-title":"Influence of the gut microbiome, diet, and environment on risk of colorectal cancer","volume":"158","author":"Song","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb1160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2013.226450","article-title":"Barrett esophagus and risk of esophageal cancer","volume":"310","author":"Spechler","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.gastro.2018.03.047","article-title":"Detection of mutations in Barrett\u2019s esophagus before progression to high-grade dysplasia or adenocarcinoma","volume":"155","author":"Stachler","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/metabo13010087","article-title":"Links between metabolic syndrome and hypertension: The relationship with the current antidiabetic drugs","volume":"13","author":"Stanciu","year":"2023","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb1175","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","article-title":"Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk","volume":"23","author":"Stern","year":"2016","journal-title":"Cell Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1180","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/HYPERTENSIONAHA.111.189258","article-title":"Blood pressure and risk of cancer incidence and mortality in the metabolic syndrome and cancer project","volume":"59","author":"Stocks","year":"2012","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb1185","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/annonc\/mdn736","article-title":"Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172 210 men and women: A prospective 19-year follow-up study","volume":"20","author":"Strasak","year":"2009","journal-title":"Annals of Oncology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb1190","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1007\/s13277-015-3047-5","article-title":"SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism","volume":"36","author":"Sun","year":"2015","journal-title":"Tumor Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb1195","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb1200","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2468-2667(18)30267-6","article-title":"Emerging cancer trends among young adults in the USA: Analysis of a population-based cancer registry","volume":"4","author":"Sung","year":"2019","journal-title":"The Lancet Public Health"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1205","doi-asserted-by":"crossref","DOI":"10.3390\/ph16010115","article-title":"Metformin induces apoptosis in human pancreatic cancer (PC) cells accompanied by changes in the levels of histone acetyltransferases (particularly, p300\/CBP-associated factor (PCAF) protein levels)","volume":"16","author":"Szymczak-Pajor","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb1210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10552-023-01797-6","article-title":"Association between hypertension grades and cancer mortality among Japanese men and women","volume":"35","author":"Tanabe","year":"2024","journal-title":"Cancer Causes & Control"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb1215","first-page":"10","article-title":"Correlation of fasting lipid profile in patients with chronic liver disease: A descriptive cross-sectional study in tertiary care hospital","volume":"12","author":"Tauseef","year":"2020","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1220","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1158\/1055-9965.EPI-12-1347","article-title":"Squamous dysplasia-the precursor lesion for esophageal squamous cell carcinoma","volume":"22","author":"Taylor","year":"2013","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-43498-9","article-title":"Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice","volume":"13","author":"Teper","year":"2023","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb1230","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.901559","article-title":"Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"13","author":"Tong","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/07853890.2018.1453168","article-title":"Pancreatic cancer subtypes: A roadmap for precision medicine","volume":"50","author":"Torres","year":"2018","journal-title":"Annals of Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb1245","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/cncr.34027","article-title":"Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study","volume":"128","author":"Tran","year":"2022","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1250","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1210\/en.2005-1012","article-title":"Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo","volume":"147","author":"Tran","year":"2006","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb1255","doi-asserted-by":"crossref","first-page":"13832","DOI":"10.18632\/oncotarget.14640","article-title":"Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway","volume":"8","author":"Tsai","year":"2017","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.pharmthera.2025.108847_bb1260","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4251\/wjgo.v14.i1.110","article-title":"Statin as a therapeutic agent in gastroenterological cancer","volume":"14","author":"Uemura","year":"2022","journal-title":"World Journal of Gastrointestinal Oncology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1270","doi-asserted-by":"crossref","DOI":"10.1007\/s11357-024-01375-x","article-title":"Overweight and obesity significantly increase colorectal cancer risk: A meta-analysis of 66 studies revealing a 25\u201357% elevation in risk","author":"Ungvari","year":"2024","journal-title":"GeroScience"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1275","doi-asserted-by":"crossref","DOI":"10.4081\/monaldi.2021.1602","article-title":"Modulation of insulin resistance by renin angiotensin system inhibitors: Implications for cardiovascular prevention","volume":"91","author":"Valente","year":"2021","journal-title":"Monaldi Archives for Chest Disease"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108847_bb1280","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/gut.2010.225011","article-title":"Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European prospective investigation into cancer and nutrition","volume":"60","author":"Van Duijnhoven","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1285","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37341","article-title":"Role of diet in colorectal cancer incidence","volume":"4","author":"Veettil","year":"2021","journal-title":"JAMA Network Open"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108847_bb1290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212409","article-title":"Diabetes and colorectal cancer risk: A new look at molecular mechanisms and potential role of novel antidiabetic agents","volume":"22","author":"Vekic","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1295","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00230","article-title":"The insulin\/IGF system in colorectal cancer development and resistance to therapy","volume":"5","author":"Vigneri","year":"2015","journal-title":"Frontiers in Oncology"},{"issue":"9791","key":"10.1016\/j.pharmthera.2025.108847_bb1300","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"The Lancet"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb1305","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1136\/gutjnl-2018-317592","article-title":"Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years","volume":"68","author":"Vuik","year":"2019","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1310","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1159\/000477890","article-title":"Cholesterol enhances colorectal cancer progression via ROS elevation and MAPK signaling pathway activation","volume":"42","author":"Wang","year":"2017","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb1315","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.21305","article-title":"Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Network Open"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1320","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2217\/hep-2016-0012","article-title":"Dysregulated fatty acid metabolism in hepatocellular carcinoma","volume":"3","author":"Wang","year":"2016","journal-title":"Hepatic Oncology"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108847_bb1325","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3390\/nu14224938","article-title":"Temporal association of total serum cholesterol and pancreatic cancer incidence","volume":"14","author":"Wang","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1330","doi-asserted-by":"crossref","first-page":"0","DOI":"10.1093\/jncics\/pkad043","article-title":"Diabetes, metformin use, and survival in esophageal cancer: A population-based cohort study","volume":"7","author":"Wang","year":"2023","journal-title":"JNCI Cancer Spectrum"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1197-x","article-title":"Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma","volume":"15","author":"Weinmann","year":"2015","journal-title":"BMC Cancer"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108847_bb1340","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.3390\/cells11223688","article-title":"Sex-dependent differences in colorectal cancer: With a focus on obesity","volume":"11","author":"Wele","year":"2022","journal-title":"Cells"},{"issue":"06","key":"10.1016\/j.pharmthera.2025.108847_bb1345","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-0029-1225717","article-title":"Metabolic syndrome increases the risk of primary liver cancer (HCC, CCC) in the United States: A population-based case-control study","volume":"47","author":"Welzel","year":"2009","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb1350","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly Semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb1355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076192","article-title":"Systematic review and meta-analysis of the impact of bariatric surgery on future cancer risk","volume":"24","author":"Wilson","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1360","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/792034","article-title":"Serum lipids and the risk of gastrointestinal malignancies in the swedish AMORIS study","volume":"2012","author":"Wulaningsih","year":"2012","journal-title":"Journal of Cancer Epidemiology"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb1365","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1002\/ijc.33172","article-title":"Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study","volume":"147","author":"Xia","year":"2020","journal-title":"International Journal of Cancer"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1370","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14750","article-title":"Obesity is associated with higher prevalence of gastroesophageal reflux disease and reflux related complications: A global healthcare database study","volume":"36","author":"Xie","year":"2024","journal-title":"Neurogastroenterology and Motility"},{"issue":"35","key":"10.1016\/j.pharmthera.2025.108847_bb1375","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007944","article-title":"Diabetes mellitus carries a risk of esophageal cancer","volume":"96","author":"Xu","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1380","first-page":"1","article-title":"Obesity and early-onset colorectal cancer risk: Emerging clinical evidence and biological mechanisms","volume":"14","author":"Xu","year":"2024","journal-title":"Frontiers in Oncology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb1385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288111","article-title":"Association between blood lipid levels and risk of gastric cancer: A systematic review and meta-analysis","volume":"18","author":"Xu","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108847_bb1390","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10120-019-01033-8","article-title":"Diabetes mellitus is associated with an increased risk of gastric cancer: A cohort study","volume":"23","author":"Yang","year":"2020","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108847_bb1395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027326","article-title":"The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: A meta-analysis of prospective cohort studies","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb1400","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052373","article-title":"Relationship between serum lipid level and colorectal cancer: A systemic review and meta-analysis","volume":"12","author":"Yang","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1405","first-page":"257","article-title":"Dyslipidemia and colorectal cancer risk: A meta-analysis of prospective studies","volume":"26","author":"Yao","year":"2015","journal-title":"Cancer Causes and Control"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108847_bb1410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines10050955","article-title":"Metformin enhancement of therapeutic effects of 5-fluorouracil and Oxaliplatin in colon cancer cells and nude mice","volume":"10","author":"Yip","year":"2022","journal-title":"Biomedicines"},{"issue":"14","key":"10.1016\/j.pharmthera.2025.108847_bb1415","doi-asserted-by":"crossref","first-page":"12748","DOI":"10.18632\/oncotarget.3327","article-title":"Metformin potentiates rapamycin and cisplatin in gastric cancer in mice","volume":"6","author":"Yu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1420","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1747326","article-title":"Diabetes and colorectal cancer risk: Clinical and therapeutic implications","volume":"2022","author":"Yu","year":"2022","journal-title":"Journal of Diabetes Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01205-8","article-title":"Nano delivery of simvastatin targets liver sinusoidal endothelial cells to remodel tumor microenvironment for hepatocellular carcinoma","volume":"20","author":"Yu","year":"2022","journal-title":"Journal of Nanobiotechnology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108847_bb1430","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.annonc.2022.03.276","article-title":"The age-dependent association of risk factors with pancreatic cancer","volume":"33","author":"Yuan","year":"2022","journal-title":"Annals of Oncology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1435","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1158\/1055-9965.EPI-22-1170","article-title":"Serum lipid profiles and cholesterol-lowering medication use in relation to subsequent risk of colorectal cancer in the UK biobank cohort","volume":"32","author":"Yuan","year":"2023","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108847_bb1440","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/ajg.2011.301","article-title":"Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer?","volume":"106","author":"Yuhara","year":"2011","journal-title":"The American Journal of Gastroenterology"},{"issue":"19","key":"10.1016\/j.pharmthera.2025.108847_bb1445","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.3390\/cancers15194787","article-title":"Unraveling the anticancer potential of statins: Mechanisms and clinical significance","volume":"15","author":"Zaky","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108847_bb1450","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/jgh.16477","article-title":"Metabolic syndrome, its components, and gastrointestinal cancer risk: A meta-analysis of 31 prospective cohorts and Mendelian randomization study","volume":"39","author":"Zhan","year":"2024","journal-title":"Journal of Gastroenterology and Hepatology (Australia)"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-023-11537-3","article-title":"Association between metabolic syndrome and early-stage colorectal cancer","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1460","article-title":"Metabolic diseases and healthy aging: Identifying environmental and behavioral risk factors and promoting public health","volume":"11","author":"Zhang","year":"2023","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1465","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114111","article-title":"Niemann-pick C1-like 1 inhibitors for reducing cholesterol absorption","volume":"230","author":"Zhang","year":"2022","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108847_bb1470","first-page":"1","article-title":"Pancreatic cancer is associated with medication changes prior to clinical diagnosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108847_bb1475","first-page":"943","article-title":"Association between blood lipid levels and the risk of liver cancer: A systematic review and meta-analysis","volume":"35","author":"Zhang","year":"2024","journal-title":"Cancer Causes and Control"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb1480","first-page":"761","article-title":"Adenocarcinomas of the esophagus and gastric cardia: Medical conditions, tobacco, alcohol, and socioeconomic factors","volume":"5","author":"Zhang","year":"1996","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108847_bb1485","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/dom.12291","article-title":"Activation of glucagon-like peptide-1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K\/Akt pathway","volume":"16","author":"Zhao","year":"2014","journal-title":"Diabetes, Obesity & Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1490","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/JME-19-0186","article-title":"Activation of GLP-1 receptor enhances the chemosensitivity of pancreatic cancer cells","volume":"64","author":"Zhao","year":"2020","journal-title":"Journal of Molecular Endocrinology"},{"issue":"19","key":"10.1016\/j.pharmthera.2025.108847_bb1495","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1158\/1078-0432.CCR-13-0203","article-title":"Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma","volume":"19","author":"Zheng","year":"2013","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1500","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.762828","article-title":"Cholesterol metabolism: A double-edged sword in hepatocellular carcinoma","volume":"9","author":"Zhou","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1505","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.biopha.2018.07.085","article-title":"A preclinical overview of metformin for the treatment of type 2 diabetes","volume":"106","author":"Zhou","year":"2018","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.pharmthera.2025.108847_bb1510","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1387243","article-title":"Comprehensively prognostic and immunological analyses of GLP-1 signaling-related genes in pan-cancer and validation in colorectal cancer","volume":"15","author":"Zhu","year":"2024","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108847_bb1515","first-page":"321","article-title":"Combination of metformin and oxaliplatin inhibits gastric cancer cell proliferation and induces apoptosis","volume":"69","author":"Zhu","year":"2022","journal-title":"Acta Biochimica Polonica"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108847_bb1520","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.clon.2008.07.005","article-title":"Helicobacter pylori infection and Oesophageal cancer risk: Association studies via evidence-based meta-analyses","volume":"20","author":"Zhuo","year":"2008","journal-title":"Clinical Oncology"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:31:14Z","timestamp":1762248674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725825000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":304,"alternative-id":["S0163725825000592"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108847","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The multifaceted role of agents counteracting metabolic syndrome: A new hope for gastrointestinal cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108847"}}